These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38865038)

  • 41. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulatory landscape of nanotechnology and nanoplastics from a global perspective.
    Allan J; Belz S; Hoeveler A; Hugas M; Okuda H; Patri A; Rauscher H; Silva P; Slikker W; Sokull-Kluettgen B; Tong W; Anklam E
    Regul Toxicol Pharmacol; 2021 Jun; 122():104885. PubMed ID: 33617940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The inaugural Qatar Critical Care Conference with its Qatar Medical Journal Special Issue - An important milestone.
    Hassan IF; Alinier G
    Qatar Med J; 2019; 2019(2):1. PubMed ID: 31763204
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Canadian Adjuvant Initiative Workshop, March 26-27, 2013--Ottawa, Canada.
    Krishnan L; Twine S; Gerdts V; Barreto L; Richards JC
    Hum Vaccin Immunother; 2014; 10(2):519-26. PubMed ID: 24192752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Establishment of Ph. Eur. Bordetella pertussis mouse antiserum Biological Reference Preparation batches 2, 3 and 4.
    Morgeaux S; Chagnaud P; Variot P; Le Tallec D; Behr-Gross ME
    Pharmeur Bio Sci Notes; 2020; 2020():161-202. PubMed ID: 32788038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Workshop report: Immunoassay standardisation for "universal" influenza vaccines.
    Pavlova S; D'Alessio F; Houard S; Remarque EJ; Stockhofe N; Engelhardt OG
    Influenza Other Respir Viruses; 2017 May; 11(3):194-201. PubMed ID: 28146323
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determination of procoagulant activity in human normal immunoglobulin preparations for therapeutic use by FXIa chromogenic assay: Evaluation of test kit sensitivity, reference standard performance and product formulation effects on the FXIa assay.
    Behr-Gross ME; Le Tallec D; Sinitskaya N; Milne C; Etscheid M
    Pharmeur Bio Sci Notes; 2024; 2024():27-75. PubMed ID: 38533680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safe- and sustainable-by-design: The case of Smart Nanomaterials. A perspective based on a European workshop.
    Mech A; Gottardo S; Amenta V; Amodio A; Belz S; Bøwadt S; Drbohlavová J; Farcal L; Jantunen P; Małyska A; Rasmussen K; Riego Sintes J; Rauscher H
    Regul Toxicol Pharmacol; 2022 Feb; 128():105093. PubMed ID: 34864125
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emerging Standards and Analytical Science for Nanoenabled Medical Products.
    Nelson BC; Minelli C; Doak SH; Roesslein M
    Annu Rev Anal Chem (Palo Alto Calif); 2020 Jun; 13(1):431-452. PubMed ID: 32084321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Maintaining the quality of vaccines through the use of standards: Current challenges and future opportunities.
    Sajjadi NC; Brady R; Jungbäck C; Mallet L; Milne C; Prior S; Pulle G; Rigsby P; Schofield T; Siggers R; Smith D; Stickings P; Uhlrich S; Van Molle W; Walker A; Wu T; Zhou T; Baca-Estrada M
    Biologicals; 2024 May; 86():101756. PubMed ID: 38479213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New European legislation and its relation to methods performance criteria and standardization.
    Brown RH
    Appl Occup Environ Hyg; 2000 Jan; 15(1):100-5. PubMed ID: 10660995
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicines.
    Ehmann F; Sakai-Kato K; Duncan R; Hernán Pérez de la Ossa D; Pita R; Vidal JM; Kohli A; Tothfalusi L; Sanh A; Tinton S; Robert JL; Silva Lima B; Amati MP
    Nanomedicine (Lond); 2013 May; 8(5):849-56. PubMed ID: 23656268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Feeding Next-Generation Nanomedicines to Europe: Regulatory and Quality Challenges.
    Musazzi UM; Franzè S; Condorelli F; Minghetti P; Caliceti P
    Adv Healthc Mater; 2023 Dec; 12(30):e2301956. PubMed ID: 37718353
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Participation of industry experts in the elaboration of monographs and chapters of the European Pharmacopoeia.
    Rose U
    Eur J Pharm Sci; 2016 Oct; 93():504-6. PubMed ID: 27131607
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanomedicines: The magic bullets reaching their target?
    Flühmann B; Ntai I; Borchard G; Simoens S; Mühlebach S
    Eur J Pharm Sci; 2019 Feb; 128():73-80. PubMed ID: 30465818
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Collaborative study for the establishment of erythropoietin BRP batch 4.
    Burns C; Bristow AF; Daas A; Costanzo A
    Pharmeur Bio Sci Notes; 2015; 2015():246-53. PubMed ID: 26830170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TRANSVAC workshop on standardisation and harmonisation of analytical platforms for HIV, TB and malaria vaccines: 'how can big data help?'.
    Dutruel C; Thole J; Geels M; Mollenkopf HJ; Ottenhoff T; Guzman CA; Fletcher HA; Leroy O; Kaufmann SHE
    Vaccine; 2014 Jul; 32(35):4365-4368. PubMed ID: 24950356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Are we asking the right questions? Working with the LGBTQ+ community to prioritise healthcare research themes.
    Crowe S; Barker E; Roberts M; Lloyd L; de Barros CM; Rebelo-Harris B; Meads C; Saunders CL
    Res Involv Engagem; 2021 Sep; 7(1):64. PubMed ID: 34556178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The perspective on standardisation and harmonisation: the viewpoint of the EASI president.
    Damoiseaux J
    Auto Immun Highlights; 2020 Feb; 11(1):4. PubMed ID: 32127033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.